BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38197757)

  • 1. Inpatient FDG PET/CT: Counterpoint-A Costly Yet Subpar Evaluation That Prolongs Hospital Length of Stay.
    Dietsche E; Scaringi J
    AJR Am J Roentgenol; 2024 Jan; ():. PubMed ID: 38197757
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
    Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
    J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current situation and cost-effectiveness of
    Chen JC; Wang Q; Li Y; Zhao YY; Gao P; Qiu LH; Hao KJ; Li HB; Yue MG; Zhou YS; Zhu JH; Gao Y; Gao ZC
    Eur J Radiol; 2022 Mar; 148():110184. PubMed ID: 35121332
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pijl JP; Glaudemans AWJM; Slart RHJA; Kwee TC
    J Nucl Med; 2018 Nov; 59(11):1734-1741. PubMed ID: 29653972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analytic model to determine the least costly inpatient erythropoiesis stimulating therapy regimen.
    Sikand H; Decter A; Greco T; Watson SH; Kang YJ; Mody SH; Piech CT; Duh MS; Naeem A
    Ann Pharmacother; 2008 Jan; 42(1):16-23. PubMed ID: 18029428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of
    Liu S; Zhang J; Yin H; Pang L; Wu B; Shi H
    Int Wound J; 2020 Aug; 17(4):1019-1027. PubMed ID: 32298049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, Determinants, and Costs of Recommendations for Additional Imaging in Clinical
    Alesawi HM; Yakar D; Glaudemans AWJM; Kwee TC
    J Nucl Med; 2019 Sep; 60(9):1228-1233. PubMed ID: 30796168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET or PET/CT in Fever of Unknown Origin: The Diagnostic Role of Underlying Primary Disease.
    Ergül N; Cermik TF
    Int J Mol Imaging; 2011; 2011():318051. PubMed ID: 21490728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Usefulness of ¹⁸F-FDG PET/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis.
    Tseng JR; Lin CW; Chen SH; Yen TH; Lin PY; Lee MH; Yen TC
    J Nucl Med; 2015 May; 56(5):681-7. PubMed ID: 25766894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.
    Benz MR; Armstrong WR; Ceci F; Polverari G; Donahue TR; Wainberg ZA; Quon A; Auerbach M; Girgis MD; Herrmann K; Czernin J; Calais J
    J Nucl Med; 2022 Feb; 63(2):199-204. PubMed ID: 34272317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging quality of F-18-FDG PET/CT in the inpatient versus outpatient setting.
    Yan X; Kang J; Zhou Y; Ehsan R; Halkar R; Applegate KE; Schuster DM
    Ann Nucl Med; 2013 Jul; 27(6):508-14. PubMed ID: 23479325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated FDG PET/CT: Utility and Applications in Clinical Oncology.
    Pinilla I; Rodríguez-Vigil B; Gómez-León N
    Clin Med Oncol; 2008; 2():181-98. PubMed ID: 21892279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
    Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
    Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
    Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Healed Status in Tuberculosis of Spine by Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography and Contrast Magnetic Resonance Imaging.
    Mittal S; Jain AK; Chakraborti KL; Aggarwal AN; Upreti L; Bhayana H
    Indian J Orthop; 2019; 53(1):160-168. PubMed ID: 30905997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
    Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
    World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT evaluation of children and young adults with suspected spinal fusion hardware infection.
    Bagrosky BM; Hayes KL; Koo PJ; Fenton LZ
    Pediatr Radiol; 2013 Aug; 43(8):991-1000. PubMed ID: 23455308
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Albano D; Durmo R; Treglia G; Giubbini R; Bertagna F
    Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):137-146. PubMed ID: 32029397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Counterpoint-No, Not So Fast!
    Moradi F; Iagaru A
    AJR Am J Roentgenol; 2021 Feb; 216(2):307-308. PubMed ID: 32755204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.